Services

Health Economics and Outcomes Research

With access to comprehensive real-world data (RWD), our award-winning data and statistics experts develop real-world evidence (RWE), supporting data-driven decision making and market differentiation.

Overview

Beyond the Limits of
Clinical Trials

Clinical trials remain the gold standard for assessing the safety and efficacy of a medical product. Yet, as more drugs obtain accelerated approval, FDA seeks to complement clinical trial results with real-world data that provide a fuller picture of product safety and effectiveness. Health Economics and Outcomes Research (HEOR) can play a crucial role in assembling that picture, as well as in highlighting advantages of specific therapies that manufacturers can use to differentiate their products from alternatives (e.g., preferred by patients, fewer side effects, lower total cost of care, and improved quality of life).

Data sources for HEOR are readily available, but the data themselves offer only a partial picture. Clients seeking accurate, real-world assessments of patient outcomes and costs must partner with someone who can access a wider range of data assets, assess them, and advise accordingly to address strategic business priorities.


Providing Clients with Actionable Insights

Our team includes well published researchers, pharmacists, and physicians as well as statisticians, health economists, and other public health experts who have worked for payers, providers, government agencies, and pharmaceutical companies. We apply this broad perspective to a wide range of datasets, thus providing clients with the real-world information and analysis needed to optimize early clinical development.

How Can We Help?
Engage An Avalere Expert Today.
Learn how our experts can deliver customized analysis and actionable insights.
Connect with an expert
Back To Top